4-Hydroxy-N-isopropyl-2-oxo-1H-1,7-naphthyridine-3-carboxamide

ID: ALA4520567

PubChem CID: 155542131

Max Phase: Preclinical

Molecular Formula: C12H13N3O3

Molecular Weight: 247.25

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)NC(=O)c1c(O)c2ccncc2[nH]c1=O

Standard InChI:  InChI=1S/C12H13N3O3/c1-6(2)14-11(17)9-10(16)7-3-4-13-5-8(7)15-12(9)18/h3-6H,1-2H3,(H,14,17)(H2,15,16,18)

Standard InChI Key:  HFJTWTAUIITCDF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
   16.8831  -13.4754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8819  -14.2949    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.5900  -14.7039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5882  -13.0665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2968  -13.4718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3002  -14.2970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0126  -14.7044    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7261  -14.2911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7227  -13.4659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0058  -13.0540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4350  -14.6978    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0013  -12.2368    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.4292  -13.0551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1382  -13.4615    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.4267  -12.2379    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.8446  -13.0507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8421  -12.2336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5536  -13.4572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  8 11  2  0
 10 12  1  0
  9 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4520567

    ---

Associated Targets(Human)

KDM5A Tchem Lysine-specific demethylase 5A (893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 247.25Molecular Weight (Monoisotopic): 247.0957AlogP: 0.77#Rotatable Bonds: 2
Polar Surface Area: 95.08Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 5.19CX Basic pKa: 3.50CX LogP: -0.75CX LogD: -2.74
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.73Np Likeness Score: -0.66

References

1. Labadie SS, Dragovich PS, Cummings RT, Deshmukh G, Gustafson A, Han N, Harmange JC, Kiefer JR, Li Y, Liang J, Liederer BM, Liu Y, Manieri W, Mao W, Murray L, Ortwine DF, Trojer P, VanderPorten E, Vinogradova M, Wen L..  (2016)  Design and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors.,  26  (18): [PMID:27499454] [10.1016/j.bmcl.2016.07.070]

Source